Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-06INSM144William Lewis plan to sell securities of INSMED INC under Form 144MEDIUM
William Lewis filed Form 144 to notify SEC of plan to sell 10699 units of INSMED INC securities around 2026-04-06, with aggregate market value of $1,746,319.00. The total outstanding units is 215551896.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months inc...
Mega CapBiotechnology
2026-04-06INSMED Inc144William Lewis plan to sell securities of INSMED INC under Form 144DuplicateMEDIUM
William Lewis filed Form 144 to notify SEC of plan to sell 10699 units of INSMED INC securities around 2026-04-06, with aggregate market value of $1,746,319.00. The total outstanding units is 215551896.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months inc...
Mega CapBiotechnology
2026-04-06LXEO144Richard Nolan Townsend plan to sell securities of Lexeo Therapeutics, Inc. under Form 144MEDIUM
Richard Nolan Townsend filed Form 144 to notify SEC of plan to sell 55000 units of Lexeo Therapeutics, Inc. securities around 2026-04-06, with aggregate market value of $314,600.00. The total outstanding units is 74087063.0. The amount planned to be sold represents 0.07% of total outstanding units; ...
Small CapBiotechnology
2026-04-06CTNM144DANIEL LORRAIN plan to sell securities of CONTINEUM THERAPEUTIC INC under Form 144MEDIUM
DANIEL LORRAIN filed Form 144 to notify SEC of plan to sell 914 units of CONTINEUM THERAPEUTIC INC securities around 2026-04-06, with aggregate market value of $12,284.16. The total outstanding units is 32673536.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 ...
Small CapBiotechnology